Physiotel digital series implant, temperature and activity
Ended Awarded Last action
- Contract number
- HT009023FG0610032
- Awardee
-
Harvard Bioscience Inc. UEI MUGFN52A5NJ1 Part of Harvard Bioscience Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $10,870
Award facts
- Contract value 100% obligated
- $10,870.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Medical Command Department of the Army, Department of Defense
- NAICS code
- 339113 Surgical Appliance and Supplies Manufacturing
- Set-aside
- No set-aside
- Competition
- 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Mounds View, MN 55112, USA
Award details come from SAM.gov/FPDS.
About this award
Harvard Bioscience Inc., operating through its Data Sciences International division, received a $10,870 firm fixed-price Blanket Purchase Agreement (BPA) call order from the U.S. Army Medical Command on June 9, 2023, for PhysioTel Digital Series implants with temperature and activity monitoring capabilities. The work is scheduled for completion by September 30, 2023, with performance conducted at the company's facility in Mounds View, Minnesota. This award was issued without a set-aside designation and represents a task order under Harvard Bioscience's existing $4.8 million Defense Health Agency BPA established in May 2022, which serves as an indefinite delivery vehicle enabling efficient procurement of specialized biomedical research equipment and services across the defense and military health system.
Harvard Bioscience is a self-certified small disadvantaged business specializing in the development and manufacturing of advanced physiological monitoring technologies for preclinical and medical research applications. The company's PhysioTel implantable telemetry systems are critical tools utilized by the Department of Defense and military healthcare organizations for wireless monitoring of physiological parameters in laboratory animal models. Under the Defense Health Agency BPA, the company has generated over $1.5 million in cumulative procurement value through individual call orders, supporting diverse requirements including telemetry devices, pre-implanted research animals, surgical services, software systems, and specialized research instrumentation at multiple performance locations including facilities in Maryland and Texas.
Quick answers
Who was awarded contract HT009023FG0610032?
HT009023FG0610032 was awarded to Harvard Bioscience Inc. by Defense Health Agency (Department of Defense) on June 9, 2023.
How much is contract HT009023FG0610032 worth?
The government has obligated $10,870 on HT009023FG0610032.
Which agency awarded contract HT009023FG0610032?
Defense Health Agency (Department of Defense) awarded HT009023FG0610032, with funding from Medical Command (Department of the Army).
Is contract HT009023FG0610032 an order under another contract?
Yes. HT009023FG0610032 is a BPA call under W81XWH22A0001, a blanket purchase agreement.
Was contract HT009023FG0610032 competed?
The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award